SUSAN JEFFERSON: Open Payments
NPI 1851038723 · IRVINGTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$373 in 19 payments from 9 companies in 2025. Trend: 2023 $93 · 2024 $196 · 2025 $373
Food & beverage: $373
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 4 | $67 |
| Teva Pharmaceuticals USA, Inc. | 1 | $61 |
| ABBVIE INC. | 3 | $59 |
| Lundbeck LLC | 3 | $53 |
| Alkermes, Inc. | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| Indivior Inc. | 1 | $17 |
Products named: INVEGA SUSTENNA, AUSTEDO XR, VRAYLAR, ABILIFY ASIMTUFII, ARISTADA, REXULTI, HETLIOZ, INGREZZA.
Industry payments across NJ — which companies pay providers there.
